Nicola Martinelli Selected Research

Apolipoprotein C-III

1/2021	High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin.
2/2019	Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation.
1/2019	Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels.
1/2018	Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease.
11/2013	Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.
4/2007	The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
2/2005	Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin-resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction.
12/2003	Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Martinelli Research Topics

Disease

30	Coronary Artery Disease (Coronary Atherosclerosis) 05/2021 - 05/2003
11	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 02/2005
10	Myocardial Infarction 01/2016 - 09/2004
6	Hypertension (High Blood Pressure) 01/2021 - 09/2007
6	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 11/2009
5	Atherosclerosis 01/2018 - 12/2003
5	Inflammation (Inflammations) 05/2013 - 03/2007
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 12/2003
4	Chronic Urticaria 01/2011 - 09/2004
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 07/2017
3	Rheumatoid Arthritis 01/2021 - 11/2005
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 02/2014
3	Neoplasms (Cancer) 01/2017 - 03/2013
3	Hyperhomocysteinemia 02/2011 - 05/2003
3	Pruritus (Itching) 01/2011 - 09/2004
3	Asthma (Bronchial Asthma) 05/2009 - 04/2003
2	Hemophilia A (Haemophilia) 01/2022 - 01/2019
2	Stroke (Strokes) 01/2021 - 01/2020
2	Atrial Fibrillation 01/2021 - 01/2020
2	Cholangiocarcinoma 01/2017 - 01/2016
2	Infections 12/2015 - 01/2015
2	Carcinogenesis 03/2013 - 06/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2012 - 08/2010
2	Iron Overload 01/2012 - 11/2009
2	Peripheral Arterial Disease 07/2009 - 09/2007
2	Systemic Scleroderma (Systemic Sclerosis) 07/2009 - 02/2003
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2009 - 01/2006
2	Hypersensitivity (Allergy) 01/2006 - 11/2005
2	Urticaria (Hives) 11/2005 - 04/2003
1	Ischemic Stroke 01/2021
1	Essential Hypertension 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Disease Susceptibility (Diathesis) 02/2019
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

11	LipidsIBA 01/2021 - 02/2005
8	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2003
8	Apolipoprotein C-IIIIBA 01/2021 - 12/2003
6	C-Reactive ProteinIBA 01/2011 - 12/2003
5	Biomarkers (Surrogate Marker)IBA 05/2021 - 03/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2006
5	HepcidinsIBA 01/2014 - 11/2009
5	IronIBA 05/2013 - 08/2005
4	Lipoproteins (Lipoprotein)IBA 01/2021 - 12/2003
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 11/2010
3	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 12/2010
3	CoagulantsIBA 01/2021 - 12/2010
3	AnticoagulantsIBA 01/2021 - 01/2019
3	AntibodiesIBA 01/2021 - 12/2003
3	Factor VIIa (Activated Factor VII)IBA 01/2020 - 09/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 02/2005
3	VaccinesIBA 01/2018 - 08/2013
3	Aryldialkylphosphatase (Paraoxonase)IBA 05/2013 - 01/2009
3	Folic Acid (Vitamin M)FDA LinkGeneric 03/2013 - 05/2003
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2009 - 02/2005
3	Ointments (Pastes)IBA 03/2008 - 09/2006
3	Tacrolimus (Prograf)FDA LinkGeneric 03/2008 - 09/2006
2	AutoantibodiesIBA 01/2021 - 01/2006
2	Messenger RNA (mRNA)IBA 01/2021 - 10/2020
2	SteroidsIBA 01/2021 - 11/2006
2	AntigensIBA 01/2021 - 01/2011
2	Myristic Acid (Tetradecanoic Acid)IBA 10/2020 - 01/2018
2	Thrombin FDA Link 02/2019 - 07/2017
2	CholesterolIBA 01/2018 - 12/2013
2	CarbonIBA 01/2017 - 01/2016
2	NucleotidesIBA 01/2017 - 01/2016
2	LDL CholesterolIBA 02/2014 - 12/2013
2	Particulate MatterIBA 06/2013 - 01/2012
2	Factor VII (Proconvertin)IBA 03/2012 - 09/2004
2	Insulin (Novolin)FDA Link 01/2012 - 02/2005
2	VitaminsIBA 02/2011 - 06/2004
2	EnzymesIBA 01/2011 - 01/2009
2	Peptides (Polypeptides)IBA 11/2009 - 11/2005
2	Arachidonic Acid (Vitamin F)IBA 10/2008 - 04/2008
2	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 03/2008 - 09/2006
2	Infliximab (Remicade)FDA Link 01/2006 - 11/2005
2	Antinuclear AntibodiesIBA 01/2006 - 11/2005
1	Asialoglycoprotein ReceptorIBA 01/2022
1	Uric Acid (Urate)IBA 05/2021
1	Peptide LibraryIBA 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Protein-Arginine Deiminase Type 4IBA 01/2021
1	methylamphotericin B (AME)IBA 01/2021
1	Trace Elements (Biometals)IBA 01/2020
1	MetallothioneinIBA 01/2020
1	AntithrombinsIBA 01/2020
1	Factor X (Stuart Factor)IBA 01/2020
1	Thromboplastin (Tissue Factor)IBA 02/2019
1	ProteomeIBA 01/2019
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019
1	Complement Factor H (Factor H)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2018
1	OligonucleotidesIBA 01/2018
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2016
1	AngiopoietinsIBA 01/2016
1	P-2 (P 2)IBA 01/2016

Therapy/Procedure

7	Therapeutics 01/2021 - 09/2004
2	Secondary Prevention 05/2021 - 10/2020